Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cuban, according to Harvard Medical School researchers.
Mr. Cuban, the billionaire internet entrepreneur and owner of the NBA’s Dallas Mavericks, launched his pharmacy in January with an eye toward disrupting the $365 billion U.S. prescription-drug market by sidestepping health-insurers and selling commonly used generic medicines directly to consumers with a transparent, fixed-rate markup pricing model.
Source: finance.yahoo.com
Related posts:
Bankman-Fried’s Evasive Answers Again Irk Judge
2 Cheap Commodity Stocks That Could Be Golden
DJT stock surges to highest level since July as bets rise on Trump election odds
Headwinds to Persist for AMD Stock, but the Stock Is Too Cheap to Ignore, Says Analyst
Erdogan Unveils Extraordinary Steps to Protect Turkish Lira, Savings